The role of real world data and real world evidence in health technology assessment
Real world data (RWD) and real world evidence (RWE) is one of the most rapidly developing areas in the modern health care systems, which is caused by the development of technologies for both collecting and analyzing data, the emergence of new data sources and the formation of needs both by regulator...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2022-10-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/715 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849696896008847360 |
|---|---|
| author | E. A. Novoderezhkina S. К. Zyryanov |
| author_facet | E. A. Novoderezhkina S. К. Zyryanov |
| author_sort | E. A. Novoderezhkina |
| collection | DOAJ |
| description | Real world data (RWD) and real world evidence (RWE) is one of the most rapidly developing areas in the modern health care systems, which is caused by the development of technologies for both collecting and analyzing data, the emergence of new data sources and the formation of needs both by regulatory bodies, health technology assessment (HTA) agencies, and by the clinical and scientific communities. However, at the moment, there is no universal approach to RWD/E generation and application in the context of HTA. Over the past few years, the rate of including RWD/E in the HTA dossier has noticeably increased, but the nature of the existing guidelines and recommendations is rather fragmentary, which might create obstacles in the way of RWD/E study development and submission. The publication is aimed to describe and summarize the main and most rapidly developing spheres of RWD/E applications and analyze the possibilities of using RWD/E in various HTA areas in the world and in the Russian Federation considering the main trends in the further HTA development. |
| format | Article |
| id | doaj-art-72e859bf563a4a358550e9ed0f4c384f |
| institution | DOAJ |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| publishDate | 2022-10-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj-art-72e859bf563a4a358550e9ed0f4c384f2025-08-20T03:19:20ZrusIRBIS LLCФармакоэкономика2070-49092070-49332022-10-0115338038910.17749/2070-4909/farmakoekonomika.2022.120405The role of real world data and real world evidence in health technology assessmentE. A. Novoderezhkina0S. К. Zyryanov1Peoples’ Friendship University of RussiaPeoples’ Friendship University of RussiaReal world data (RWD) and real world evidence (RWE) is one of the most rapidly developing areas in the modern health care systems, which is caused by the development of technologies for both collecting and analyzing data, the emergence of new data sources and the formation of needs both by regulatory bodies, health technology assessment (HTA) agencies, and by the clinical and scientific communities. However, at the moment, there is no universal approach to RWD/E generation and application in the context of HTA. Over the past few years, the rate of including RWD/E in the HTA dossier has noticeably increased, but the nature of the existing guidelines and recommendations is rather fragmentary, which might create obstacles in the way of RWD/E study development and submission. The publication is aimed to describe and summarize the main and most rapidly developing spheres of RWD/E applications and analyze the possibilities of using RWD/E in various HTA areas in the world and in the Russian Federation considering the main trends in the further HTA development.https://www.pharmacoeconomics.ru/jour/article/view/715health technology assessmenthtareal world datarwdreal world evidencerwepharmacoeconomic analysishealth economics and outcomes researchheor |
| spellingShingle | E. A. Novoderezhkina S. К. Zyryanov The role of real world data and real world evidence in health technology assessment Фармакоэкономика health technology assessment hta real world data rwd real world evidence rwe pharmacoeconomic analysis health economics and outcomes research heor |
| title | The role of real world data and real world evidence in health technology assessment |
| title_full | The role of real world data and real world evidence in health technology assessment |
| title_fullStr | The role of real world data and real world evidence in health technology assessment |
| title_full_unstemmed | The role of real world data and real world evidence in health technology assessment |
| title_short | The role of real world data and real world evidence in health technology assessment |
| title_sort | role of real world data and real world evidence in health technology assessment |
| topic | health technology assessment hta real world data rwd real world evidence rwe pharmacoeconomic analysis health economics and outcomes research heor |
| url | https://www.pharmacoeconomics.ru/jour/article/view/715 |
| work_keys_str_mv | AT eanovoderezhkina theroleofrealworlddataandrealworldevidenceinhealthtechnologyassessment AT skzyryanov theroleofrealworlddataandrealworldevidenceinhealthtechnologyassessment AT eanovoderezhkina roleofrealworlddataandrealworldevidenceinhealthtechnologyassessment AT skzyryanov roleofrealworlddataandrealworldevidenceinhealthtechnologyassessment |